ConductScience.org, home

Trial · NCT05894577

Results by group150

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Time to Sustained Recovery in DaysArm F - Montelukast1095% Confidence Interval 10 to 11days
Time to Sustained Recovery in DaysArm F - Placebo1095% Confidence Interval 10 to 11days
Number of Participants With Hospitalization or DeathArm F - Montelukast2Participants
Number of Participants With Hospitalization or DeathArm F - Placebo2Participants
Number of Participants With MortalityArm F - Montelukast0Participants
Number of Participants With MortalityArm F - Placebo0Participants
Number of Participants With Hospitalization, Urgent Care, Emergency Room Visit, or DeathArm F - Montelukast18Participants
Number of Participants With Hospitalization, Urgent Care, Emergency Room Visit, or DeathArm F - Placebo18Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Montelukast0 = No clinical or virological evidence of infection22Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Placebo0 = No clinical or virological evidence of infection28Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Montelukast1 = No limitation of activities564Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Placebo1 = No limitation of activities557Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Montelukast2 = Limitation of activities20Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Placebo2 = Limitation of activities17Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Montelukast3 = Hospitalized, no oxygen therapy0Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Placebo3 = Hospitalized, no oxygen therapy0Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Montelukast4 = Hospitalized, on oxygen by mask or nasal prongs0Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Placebo4 = Hospitalized, on oxygen by mask or nasal prongs0Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Montelukast5 = Hospitalized, on non-invasive ventilation or high-flow oxygen0Participants
Number of Participants at Each Score on the COVID Clinical Progression Scale at Day 7Arm F - Placebo5 = Hospitalized, on non-invasive ventilation or high-flow oxygen0Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05894577/results